2007. Ph.D in Neurobiology, Lund University
2021. Docent in Neuroscience, Karolinska Institutet
Type 2 diabetes and stroke
Prevalence of type 2 diabetes and its complications is rapidly rising worldwide. One of the major complications of diabetes is cardiovascular disease that often leads to a stroke. Diabetes not only doubles the risk of stroke, but also significantly impairs post-stroke recovery, often leading to lasting disabilities.
Main subject of my research is the identification of the pathophysiological mechanisms by which diabetes impairs stroke recovery and the development of treatment strategies based on lifestyle and pharmacological interventions. See the research group page at: http://ki.se/en/kisos/the-neurocardiometabol-group. This research and development effort is conducted in close collaboration with academic, clinical and industrial partners and involves both clinical and preclinical settings. Besides stroke, our group is actively investigating the role of diabetes in other neurological complications that are overrepresented in the diabetic population, such as Parkinson’s disease, cognitive decline and dementias.
Project coordinator and examiner for degree projects in medicine (30hp), Department of Medical Epidemiology and Biostatistics, Karolinska Institutet.